GoodRx Holdings (GDRX) Gross Margin (2019 - 2026)

GoodRx Holdings has disclosed Gross Margin across 8 years of filings, most recently posting 58.22% for Q1 2026.

• Gross Margin for Q1 2026 came in at 58.22%, down 13.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 93.13% (up 5844.0% YoY), and the FY2025 annual result was 92.77%, up 3911.0% from the prior year.
• Gross Margin came in at 58.22% for Q1 2026 at GoodRx Holdings, down from 200.29% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 200.29% in Q4 2025 to a low of 68.33% in Q4 2022.
• The 5-year median for Gross Margin is 57.39% (2025), against an average of 52.22%.
• Across the five-year window, Gross Margin slumped 3797 bps in 2024 and jumped 26702 bps in 2025, its largest moves.
• GoodRx Holdings' Gross Margin stood at 68.33% in 2022, then jumped by 31 bps to 47.26% in 2023, then slumped by 41 bps to 66.73% in 2024, then surged by 400 bps to 200.29% in 2025, then plunged by 71 bps to 58.22% in 2026.
• The last three Gross Margin figures came in at 58.22% (Q1 2026), 200.29% (Q4 2025), and 57.39% (Q3 2025), per Business Quant data.